Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).
Open Access
- 1 November 1987
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 166 (5) , 1447-1455
- https://doi.org/10.1084/jem.166.5.1447
Abstract
The effects of B cell stimulatory factor 1 (BSF-1) on the generation of human CTL and lymphokine-activated killer (LAK) cells in vitro were investigated. Both L-2 and BSF-1 were potent helper factors for the generation of antigen-specific CTL in MLC; detection of optimal BSF-1-induced CTL activity in this system occurred when BSF-1 was added to cultures after an initial period of activation during which exogenous BSF-1 was not present. In contrast to IL-2, BSF-1 failed to induced an LAK cell population, as detected with Daudi tumor targets, in cultures that had not been allosensitized. Furthermore, when both lymphokines were added together at culture initiation, BSF-1 inhibited the IL-2-driven generation of cytolytic cells. The differential ability of BSF-1 to promote the generation of CTL but not LAK could have important implications for lymphokine-mediated immunotherapy.This publication has 23 references indexed in Scilit:
- Regulation of murine T cell proliferation by B cell stimulatory factor-1.The Journal of Immunology, 1987
- Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.The Journal of Immunology, 1987
- Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.The Journal of Immunology, 1983
- Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.The Journal of Immunology, 1983
- Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.The Journal of Experimental Medicine, 1983
- Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.The Journal of Experimental Medicine, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- A differentiation factor required for the expression of cytotoxic T-cell functionNature, 1982
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.The Journal of Immunology, 1980